See more : Janus Henderson Sustainable Cor (JLQD) Income Statement Analysis – Financial Results
Complete financial analysis of Cann Group Limited (CAN.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cann Group Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- SuperCom Ltd. (SPCB) Income Statement Analysis – Financial Results
- Sparinvest Value Aktier KL (SPIVAKLA.CO) Income Statement Analysis – Financial Results
- Willowglen MSC Berhad (0008.KL) Income Statement Analysis – Financial Results
- Estrella Resources Limited (ESR.AX) Income Statement Analysis – Financial Results
- Tryp Therapeutics Inc. (TRYPF) Income Statement Analysis – Financial Results
Cann Group Limited (CAN.AX)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.canngrouplimited.com
About Cann Group Limited
Cann Group Limited engages in the breeding, cultivation, production, manufacturing, clinical evaluation, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets. It licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Port Melbourne, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 15.37M | 13.78M | 6.41M | 4.29M | 647.22K | 2.61M | 605.65K | 8.42K | 6.66K | 13.74K |
| Cost of Revenue | 12.18M | -6.86M | -4.83M | 48.00K | 641.00K | 465.92K | 104.82K | 124.30K | 28.92K | 0.00 |
| Gross Profit | 3.20M | 20.63M | 11.24M | 4.25M | 6.22K | 2.14M | 500.83K | -115.88K | -22.26K | 13.74K |
| Gross Profit Ratio | 20.78% | 149.77% | 175.29% | 98.88% | 0.96% | 82.13% | 82.69% | -1,376.04% | -334.06% | 100.00% |
| Research & Development | 755.00K | 4.29M | 2.99M | 2.03M | 1.28M | 1.05M | 776.43K | 547.78K | 64.40K | 437.39K |
| General & Administrative | 30.44M | 34.11M | 27.70M | 23.13M | 13.85M | 13.47M | 5.00M | 1.64M | 1.10M | 945.56K |
| Selling & Marketing | 0.00 | -758.00K | -1.27M | 0.00 | 1.48K | 0.00 | 544.41K | -124.30K | 232.53K | 2.72M |
| SG&A | 30.44M | 33.35M | 26.42M | 23.13M | 13.85M | 13.47M | 5.55M | 1.52M | 1.34M | 3.67M |
| Other Expenses | -15.82M | -1.43M | -1.27M | 2.55M | 952.38K | 260.27K | 943.39K | -398.01K | 0.00 | 0.00 |
| Operating Expenses | 15.37M | 39.07M | 30.69M | 25.16M | 15.13M | 14.51M | 6.33M | 2.07M | 1.40M | 4.18M |
| Cost & Expenses | 31.84M | 51.03M | 35.49M | 27.79M | 17.29M | 14.98M | 6.43M | 2.19M | 1.43M | 4.18M |
| Interest Income | 0.00 | 3.16M | 1.83M | 41.00K | 263.36K | 1.45M | 889.36K | 549.00 | 6.28K | 12.55K |
| Interest Expense | 6.82M | 3.16M | 1.83M | 4.15M | 869.03K | 198.91K | 8.38K | 549.00 | 15.53K | 12.55K |
| Depreciation & Amortization | 11.04M | 11.96M | 4.80M | 2.63M | 2.16M | 1.48M | 846.79K | 124.30K | 28.92K | 4.16M |
| EBITDA | -35.54M | -17.76M | -19.79M | -17.29M | -13.91M | -9.51M | -3.87M | -2.46M | -1.42M | 0.00 |
| EBITDA Ratio | -231.16% | -183.60% | -378.68% | -486.05% | -2,237.78% | -414.73% | -787.33% | -24,528.92% | -21,031.97% | -91.36% |
| Operating Income | -13.48M | -37.25M | -29.07M | -23.50M | -16.64M | -12.37M | -5.62M | -2.19M | -1.43M | -4.16M |
| Operating Income Ratio | -87.68% | -270.41% | -453.50% | -547.33% | -2,571.51% | -474.40% | -927.15% | -26,004.99% | -21,466.08% | -30,300.47% |
| Total Other Income/Expenses | -37.76M | -21.98M | -11.54M | -12.70M | -1.23M | 1.45M | 950.04K | -406.98K | -15.53K | -83.02K |
| Income Before Tax | -51.24M | -39.75M | -30.99M | -29.34M | -17.88M | -10.93M | -4.73M | -2.59M | -1.46M | -4.18M |
| Income Before Tax Ratio | -333.32% | -288.49% | -483.36% | -683.37% | -2,761.85% | -418.96% | -780.30% | -30,737.98% | -21,945.53% | -30,391.84% |
| Income Tax Expense | 0.00 | -5.96M | -4.52M | -4.23M | -937.93K | -257.79K | 0.00 | 3.00 | 3.00 | -25.11K |
| Net Income | -51.24M | -33.79M | -26.47M | -25.10M | -16.94M | -10.93M | -4.73M | -2.59M | -1.46M | -4.18M |
| Net Income Ratio | -333.32% | -245.26% | -412.85% | -584.74% | -2,616.94% | -418.96% | -780.30% | -30,737.98% | -21,945.53% | -30,391.84% |
| EPS | -0.11 | -0.09 | -0.08 | -0.10 | -0.12 | -0.08 | -0.04 | -0.05 | -0.01 | 0.00 |
| EPS Diluted | -0.11 | -0.09 | -0.08 | -0.10 | -0.12 | -0.08 | -0.04 | -0.05 | -0.01 | 0.00 |
| Weighted Avg Shares Out | 453.86M | 372.25M | 337.79M | 259.46M | 143.33M | 140.82M | 125.28M | 52.75M | 109.23M | 0.00 |
| Weighted Avg Shares Out (Dil) | 453.86M | 372.25M | 337.79M | 259.46M | 143.33M | 140.82M | 125.28M | 52.75M | 109.23M | 0.00 |
Source: https://incomestatements.info
Category: Stock Reports